Our study assessed the feasibility of a novel method for real-time lesion targeting during transrectal in-bore MRI-guided prostate biopsy using a tablet device inside the MR room. Real-time targeting was technically successful in all patients and allowed targeted biopsy of the cancer suspicious region without requiring additional needle guide adjustments in all but one patient. Prostate cancer (PCa) was found in 18 of 20 patients. Our initial clinical experience indicates a substantial decrease in biopsy and procedure time as compared to standard targeting, which could be valuable to increase clinical applicability of the technique.
This abstract and the presentation materials are available to members only; a login is required.